Cerulean CEO resigns to head up San Diego biotech

The CEO of one of the many newly public Cambridge-based biotech firms, Cerulean Pharma, has resigned as of Wednesday this week to become head of San Diego-based Synthetic Genomics...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.